A number of companies in the Danish C25 stock index have published financial statements on Wednesday morning, and investors are reacting very differently to the figures they have been presented with.
Vestas' share price has risen by more than ten percent after the company delivered better than expected in the third quarter.
Ørsted is also rising slightly after financial statements that, most importantly, did not contain any more unpleasant surprises than those that have already hit the company in recent years.
On the other hand, Ambu has to endure a serious price drop. Ambu, which produces hospital equipment, has been hit by a weakened dollar and the effect of US tariffs, which have had an impact on the company's revenue growth measured in kroner. This has apparently disappointed investors so much that the share has fallen by as much as 12 percent since this morning.
Novo Nordisk, on the other hand, has escaped unscathed from lowering its expectations for this year's sales growth. Novo shares are up 0.8 percent after a quarter of an hour of trading after being down four percent shortly after the stock market opened at 9 a.m.
Overall, the Danish elite index is up 1.0 percent on a day when Pandora, Sydbank and ISS have also published financial figures.
/ritzau/
Text, graphics, images, sound, and other content on this website are protected under copyright law. DK Medier reserves all rights to the content, including the right to exploit the content for the purpose of text and data mining, cf. Section 11b of the Copyright Act and Article 4 of the DSM Directive.
Customers with IP agreements/major customer agreements may only share Danish Offshore Industry articles internally for the purpose of handling specific cases. Sharing in connection with specific cases refers to journaling, archiving, or similar uses.
Customers with a personal subscription/login may not share Danish Offshore Industry articles with individuals who do not themselves have a personal subscription to Danish Offshore Industry.
Any deviation from the above requires written consent from DK Medier.
